Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

By O'Callaghan Dermot S   Savale Laurent   Yaïïci Azzedine   Natali Delphine   Jaïïs Xavier   Parent Florence   Montani David   Humbert Marc   Simonneau Géérald   Sitbon Olivier  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1585-1596

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: Rationale and Place in Therapy

By Price Laura C.   Howard Luke S.G.E.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

By Tilton Ronald G   Brock Tommy A   Dixon Richard AF  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1291-1308

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists in Heart Failure: Current Status and Future Directions

By Ertl G.   Bauersachs J.  

Drugs, Vol. 64, Iss. 10, 2004-01 ,pp. : 1029-1040

Adis International

Access to resources Recommend Favorite

Endothelin Receptor Antagonists - An Overview

By  

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 549-575

Bentham Science Publishers

Access to resources Recommend Favorite